Roche Diagnostics Hong Kong general manager Ronald Lo is pushing the city beyond reactive medicine towards a prevention-led system powered by automation, AI and empowered patients. Roche Diagnostics Hong Kong general manager Ronald Lo is pushing the city beyond reactive medicine towards a prevention-led system powered by automation, AI and empowered patients. Time gained through early detection. Time saved by avoiding unnecessary treatment. Time extended for patients who might otherwise run out of options. Since becoming general manager of Roche Diagnostics Hong Kong in 2022, Lo has pursued what he calls his “dream” for the city: shifting healthcare away from a treatment-focused model towards one that prioritises prevention. After more than 25 years in the diagnostics industry, he believes Hong Kong now has both the urgency and the tools to make that transition real. “We wish to support Hong Kong to move out from an extreme-acute-treatment-based healthcare system to a prevention-led healthcare ecosystem,” he says. “That is always my wish, every day.” In Lo’s view, diagnostics is no longer a backstage laboratory function.
Comments
İlk yorumu siz yazın!